Trial Profile
Oral Dydrogesterone Versus Micronized Vaginal Progesterone for Luteal Phase Support in In Vitro Fertilisation (IVF)/ IntraCytoplasmic Sperm Injection (ICSI): Pharmacokinetics and the Impact on the Endometrium, the Microbiota of the Genital Tract and the Peripheral Immunology. Double Blind Crossover Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Mar 2024
Price :
$35
*
At a glance
- Drugs Dydrogesterone (Primary) ; Progesterone (Primary)
- Indications Female infertility
- Focus Therapeutic Use
- 14 Dec 2020 Status changed from recruiting to completed.
- 12 Apr 2020 Planned number of patients changed from 20 to 30.
- 22 May 2019 Planned End Date changed from 1 Jul 2020 to 1 Dec 2020.